BIOMAT Database Logo BIOMAT Database Logo

Design of potent and selective antagonists of the vasopressor responses to arginine-vasopressin. 1982

M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer

UI MeSH Term Description Entries
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004231 Diuresis An increase in the excretion of URINE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Diureses
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Design of potent antagonists of the vasopressor response to arginine-vasopressin.
September 1978, Journal of medicinal chemistry,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.
November 1990, Journal of medicinal chemistry,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Antagonists of vasopressor and antidiuretic responses to arginine vasopressin.
April 1982, Annals of internal medicine,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin.
January 1982, Journal of medicinal chemistry,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism.
April 1982, Journal of medicinal chemistry,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
[1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),4-valine,-8-D-arginine]vasopressin, a potent and selective inhibitor of the vasopressor response to arginine-vasopressin.
March 1978, Journal of medicinal chemistry,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
[1-deaminopenicillamine,4-valine]-8-D-arginine-vasopressin, a highly potent inhibitor of the vasopressor response to arginine-vasopressin.
September 1977, Journal of medicinal chemistry,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Novel linear antagonists of the antidiuretic (V2) and vasopressor (V1) responses to vasopressin.
December 1988, International journal of peptide and protein research,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Prevention of arginine-vasopressin-induced motor disturbances by a potent vasopressor antagonist.
January 1986, Brain research,
M Manning, and B Lammek, and M Kruszynski, and J Seto, and W H Sawyer
Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
April 1984, Journal of medicinal chemistry,
Copied contents to your clipboard!